Clinical Trials Logo

Citation(s)

  •   Despierre E, Lambrechts D, Neven P, Amant F, Lambrechts S, Vergote I
    The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment. Gynecol Oncol. 2010 May;117(2):358-65. doi: 10.1016/j.ygyno.2010.02.012. Epub 2010 Mar 7.
  •   Kurman RJ, Shih IeM
    The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010 Mar;34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79.
  •   Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E
    Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012 Mar;13(3):e103-15. doi: 10.1016/S1470-2045(11)70288-1.
  •   Vang R, Shih IeM, Kurman RJ
    Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009 Sep;16(5):267-82. doi: 10.1097/PAP.0b013e3181b4fffa.

Sub-type Specific Genomic Mutations in Serous Borderline Ovarian Tumors

Details for clinical trial NCT03883542